GO:0004961 thromboxane A2 receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004961 (thromboxane A2 receptor activity) is a molecular function defined as combining with thromboxane A2 (TXA2) and transmitting the signal across the membrane to activate an associated G-protein [QuickGO].
• The thromboxane A2 receptor (TBXA2R) is a G-protein-coupled receptor that couples to Gq, G12/13, and Gi to trigger calcium mobilization, Rho activation, and platelet aggregation.
• TXA2 receptor activity is central to vascular tone, hemostasis, and inflammation, and its dysregulation contributes to thrombosis, atherosclerosis, and insulin resistance [3,5,6].
• Constitutive surface expression of the TXA2 receptor is regulated by Pim kinases, revealing a novel post-translational control mechanism.
• TXA2 receptor antagonists and thromboxane synthase inhibitors are validated drug classes, with QSAR studies guiding their optimization.
• Natural flavonoids can antagonize TXA2 receptor activity, offering dietary and pharmacological leads.
Description
Thromboxane A2 receptor activity (GO:0004961) is a molecular function that mediates cellular responses to thromboxane A2 (TXA2), a labile arachidonic acid metabolite. This receptor activity is essential for transmitting signals from TXA2 across the plasma membrane to activate heterotrimeric G-proteins, thereby influencing platelet aggregation, vascular smooth muscle contraction, and inflammation. The receptor, encoded by TBXA2R, is a prototypical G-protein-coupled receptor (GPCR) that couples to Gq, G12/13, and Gi, leading to downstream effectors such as phospholipase C and Rho kinase. Researchers study GO:0004961 to understand cardiovascular physiology and disease. For example, the TXA2 receptor drives a COX-2-dependent feedback loop that affects endothelial homeostasis and angiogenesis. In the brain, TXA2 receptor activity modulates cerebral vascular tone, with implications for neurovascular coupling. Moreover, TXA2 receptor signaling contributes to hepatic insulin resistance and steatosis in non-alcoholic fatty liver disease. Given its broad pathophysiological roles, the TXA2 receptor is a target for antiplatelet and vasoactive therapies. This article provides a comprehensive overview of GO:0004961, covering its definition, mechanism, key genes, disease associations, and research methodologies, including CRISPR-based models. All facts are drawn from published literature and the QuickGO definition.
thromboxane A2 receptor activity At A Glance
| GO ID | GO:0004961 |
|---|---|
| GO term | thromboxane A2 receptor activity |
| Ontology | molecular_function |
| Synonym | TXA2 receptor activity, TXA(2) receptor activity |
| Major function | Binding thromboxane A2 and activating an associated G-protein to transmit signals across the membrane |
| Definition source | QuickGO |
| Related receptor | TBXA2R (thromboxane A2 receptor) |
| G-protein coupling | Gq, G12/13, Gi |
| Physiological roles | Platelet aggregation, vascular tone, inflammation [3,6] |
What Is GO:0004961?
According to the Gene Ontology, GO:0004961 (thromboxane A2 receptor activity) is defined as the molecular function of combining with thromboxane A2 (TXA2) and transmitting the signal across the membrane to activate an associated G-protein. In other words, it is the receptor activity that specifically binds TXA2 and initiates intracellular signaling via G-protein activation. This activity is synonymous with TXA2 receptor activity and TXA(2) receptor activity. It is a molecular function term, not a biological process or cellular component.
Why Is thromboxane A2 receptor activity Important in Cell Biology?
GO:0004961 is critically important because thromboxane A2 receptor activity governs fundamental cardiovascular and inflammatory processes. The receptor mediates platelet shape change and aggregation, vascular smooth muscle contraction, and endothelial responses, making it a key player in hemostasis and thrombosis. Dysregulated TXA2 receptor signaling is implicated in atherosclerosis, hypertension, and insulin resistance [3,5]. Pharmacological targeting of this receptor activity with antagonists or synthase inhibitors is a proven therapeutic strategy. Thus, understanding GO:0004961 at molecular, cellular, and organismal levels is essential for developing new treatments for cardiovascular and metabolic diseases.
• Mediates platelet activation and aggregation, contributing to thrombosis and hemostasis.
• Regulates vascular tone in cerebral and systemic circulation.
• Drives a COX-2-dependent feedback loop affecting endothelial homeostasis and angiogenesis.
• Contributes to hepatic insulin resistance and steatosis in non-alcoholic fatty liver disease.
• Is a target for antiplatelet drugs such as thromboxane synthase inhibitors and receptor antagonists.
• Natural flavonoids can antagonize TXA2 receptor activity, offering dietary modulation.
• Constitutive surface expression is regulated by Pim kinases, linking to kinase signaling.
• Involved in glial morphological changes via G12/13-dependent pathways.
• Plays a role in early-age efferocytosis and macrophage arachidonic acid metabolism for tissue regeneration.
• Provides a paradigm for GPCR signaling and drug discovery.
Molecular Mechanism of thromboxane A2 receptor activity
Ligand Binding and Receptor Activation
In simple terms: TXA2 binds to its receptor like a key in a lock, switching the receptor on.
Thromboxane A2 (TXA2) is synthesized from arachidonic acid via cyclooxygenase and thromboxane synthase. It binds to the thromboxane A2 receptor (TBXA2R), a seven-transmembrane GPCR, inducing a conformational change that enables the receptor to act as a guanine nucleotide exchange factor for heterotrimeric G-proteins. This binding is highly specific, as demonstrated by structure-activity relationship studies of antagonists.
G-Protein Coupling and Effector Activation
In simple terms: The activated receptor turns on G-proteins, which then relay the signal inside the cell.
The TXA2 receptor couples primarily to Gq, G12/13, and Gi. Gq activates phospholipase C-beta, leading to inositol trisphosphate production and calcium release, while G12/13 activates Rho kinase, and Gi inhibits adenylyl cyclase. This coupling triggers downstream responses such as platelet aggregation and smooth muscle contraction.
Downstream Signaling and Cellular Responses
In simple terms: The signal leads to changes in cell shape, movement, and function.
Activation of the TXA2 receptor results in calcium mobilization, activation of protein kinase C, and cytoskeletal rearrangements. In glial cells, this pathway mediates morphological changes via G12/13. In endothelial cells, it drives a COX-2-dependent feedback loop that affects angiogenesis. In hepatocytes, it contributes to endoplasmic reticulum stress and insulin resistance.
Regulation of Receptor Expression and Activity
In simple terms: Cells control how much receptor is on the surface and how active it is.
Constitutive surface expression of the TXA2 receptor is dependent on Pim kinases, which regulate receptor trafficking or stability. Additionally, receptor activity can be modulated by antagonists such as flavonoids and by feedback loops involving COX-2. These regulatory mechanisms fine-tune TXA2 signaling in different physiological contexts.
Key Genes Involved in GO:0004961 thromboxane A2 receptor activity
The following genes and proteins are central to thromboxane A2 receptor activity and its signaling network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBXA2R | Encodes the thromboxane A2 receptor, a GPCR that binds TXA2 and activates G-proteins | Primary target for studying GO:0004961; mutations linked to bleeding disorders and cardiovascular disease |
| TBXAS1 | Thromboxane A synthase 1, synthesizes TXA2 from prostaglandin H2 | Determines ligand availability for the receptor; target of thromboxane synthase inhibitors |
| PTGS2 | Cyclooxygenase-2, produces prostaglandin H2, a precursor of TXA2 | Involved in a feedback loop with the TXA2 receptor in endothelial cells |
| PTGS1 | Cyclooxygenase-1, constitutively produces prostaglandin H2 in platelets | Contributes to TXA2 synthesis in platelets; target of aspirin |
| GNAQ | Gq alpha subunit, couples to TXA2 receptor to activate phospholipase C | Mediates calcium signaling downstream of receptor activation |
| GNA12 | G12 alpha subunit, couples to TXA2 receptor to activate Rho kinase | Mediates glial morphological changes and vascular effects |
| GNA13 | G13 alpha subunit, couples to TXA2 receptor to activate Rho kinase | Mediates glial morphological changes and vascular effects |
| GNAI1 | Gi alpha subunit, couples to TXA2 receptor to inhibit adenylyl cyclase | Modulates cAMP levels downstream of receptor activation |
| PIM1 | Pim-1 kinase, regulates constitutive surface expression of TXA2 receptor | Novel regulator of receptor trafficking |
| PIM2 | Pim-2 kinase, may regulate TXA2 receptor surface expression | Potential kinase involved in receptor regulation |
| PIM3 | Pim-3 kinase, may regulate TXA2 receptor surface expression | Potential kinase involved in receptor regulation |
| PLCB1 | Phospholipase C beta 1, effector of Gq downstream of TXA2 receptor | Produces IP3 and DAG, leading to calcium release |
| RHOA | RhoA GTPase, effector of G12/13 downstream of TXA2 receptor | Mediates cytoskeletal changes and contraction |
| ROCK1 | Rho-associated kinase 1, downstream of RhoA | Mediates contractile and morphological responses |
| MAPK1 | ERK2, mitogen-activated protein kinase, activated by TXA2 receptor signaling | Contributes to cell proliferation and gene expression |
| MAPK3 | ERK1, mitogen-activated protein kinase, activated by TXA2 receptor signaling | Contributes to cell proliferation and gene expression |
| AKT1 | Protein kinase B, may be activated downstream of TXA2 receptor | Involved in cell survival and metabolism |
How Is thromboxane A2 receptor activity Regulated?
Thromboxane A2 receptor activity is regulated at multiple levels. Constitutive surface expression of the receptor depends on Pim kinases, which likely control receptor trafficking or stability. Ligand availability is regulated by the enzymes thromboxane synthase (TBXAS1) and cyclooxygenases (PTGS1/PTGS2), which synthesize TXA2 from arachidonic acid [2,3]. Additionally, a COX-2-dependent feedback loop modulates receptor signaling in endothelial cells, affecting homeostasis and angiogenesis. Antagonists such as flavonoids can directly inhibit receptor activity. These regulatory mechanisms ensure tight control of TXA2 signaling in diverse physiological contexts.
thromboxane A2 receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TBXA2R | Thrombosis, cardiovascular disease | Platelet-specific knockout or point-mutation knock-in mice |
| TBXAS1 | Thromboxane-related disorders | Liver-specific knockout or overexpression |
| PTGS2 | Inflammation, angiogenesis | Endothelial cell knockout or knock-in |
| PIM1 | Receptor trafficking, cancer | Kinase-dead knock-in or knockout |
| GNA13 | Vascular development, cancer | Conditional knockout in smooth muscle |
Cardiovascular Disease and Thrombosis
Thromboxane A2 receptor activity is critically involved in platelet aggregation and vascular tone, and its dysregulation contributes to thrombosis, atherosclerosis, and hypertension. The receptor drives a COX-2-dependent feedback loop that affects endothelial homeostasis and angiogenesis, linking it to vascular pathology. Antagonists of the receptor are used as antiplatelet agents.
Metabolic Disease and Non-Alcoholic Fatty Liver Disease
The TXA2/TXA2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non-alcoholic fatty liver disease. This highlights the receptor's role beyond the cardiovascular system, implicating it in metabolic disorders.
Neurovascular and Glial Function
TXA2 receptor activity modulates cerebral vascular tone, as shown in ex vivo studies of the cerebral cortex. In glial cells, receptor activation mediates G12/13-dependent morphological changes, suggesting roles in neuroinflammation and brain function.
Tissue Regeneration and Inflammation
Early-age efferocytosis directs macrophage arachidonic acid metabolism, which includes TXA2 production, for tissue regeneration. This links TXA2 receptor activity to inflammatory resolution and tissue repair.
From thromboxane A2 receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TBXA2R mediate platelet aggregation? | Platelet-specific TBXA2R knockout mouse |
| What is the role of Pim kinases in TXA2 receptor surface expression? | Pim1/2/3 triple knockout cell line |
| How does TXA2 receptor signaling affect hepatic insulin resistance? | Liver-specific TBXA2R overexpression or knockout |
| What is the effect of TXA2 receptor point mutations on G-protein coupling? | Point-mutation knock-in of TBXA2R in HEK293 cells |
| Can flavonoids antagonize TXA2 receptor activity? | Competitive binding assays with flavonoid treatment |
| How does TXA2 receptor activity modulate cerebral vascular tone? | Ex vivo cerebral cortex preparation with receptor agonists/antagonists |
How to Study the thromboxane A2 receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Ligand-receptor affinity and kinetics | Screening antagonists like flavonoids |
| GTPgammaS binding | G-protein activation | Quantifying receptor coupling to G-proteins |
| Calcium imaging | Intracellular calcium release | Assessing Gq-mediated signaling |
| Rho-GTP pull-down | RhoA activation | Measuring G12/13-mediated responses |
| CRISPR knockout screen | Gene essentiality for receptor expression | Identifying regulators like Pim kinases |
| Western blot | Protein expression and phosphorylation | Detecting receptor and downstream effectors |
| Immunofluorescence | Subcellular localization | Visualizing receptor surface expression |
| qRT-PCR | mRNA expression levels | Quantifying TBXA2R and related genes |
Receptor Binding Assays
Radioligand binding assays using labeled TXA2 analogs or antagonists measure the affinity and kinetics of ligand-receptor interactions. These assays are used to screen for agonists and antagonists, such as flavonoids.
G-Protein Activation Assays
GTPgammaS binding or BRET-based sensors detect G-protein activation downstream of the TXA2 receptor. These methods quantify coupling to Gq, G12/13, and Gi.
Calcium Mobilization and Rho Activation
Fluorescent calcium indicators and Rho-GTP pull-down assays measure downstream signaling events. These are used to study receptor-mediated cellular responses like platelet activation and glial morphological changes.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that regulate TXA2 receptor surface expression or signaling. For example, Pim kinases were identified as regulators of receptor expression.
How CRISPR Can Be Used to Study GO:0004961 thromboxane A2 receptor activity
Knockout
CRISPR knockout of TBXA2R or its downstream effectors (e.g., GNAQ, GNA13) can abolish TXA2 receptor activity, providing a clean background to study its function. For example, TBXA2R knockout platelets fail to aggregate in response to TXA2. Knockout of Pim kinases reduces constitutive surface expression of the receptor.
Point Mutation
Introducing point mutations in TBXA2R can dissect G-protein coupling specificity or ligand binding. For instance, mutations in the DRY motif or intracellular loops can impair Gq coupling, allowing researchers to attribute specific signaling outputs to distinct G-proteins.
Knock-in
Knock-in of tagged TBXA2R (e.g., HA or GFP) enables visualization and immunoprecipitation of the receptor in native cells. This approach can reveal trafficking dynamics and interaction partners.
Overexpression
Overexpression of TBXA2R in cell lines such as HEK293 or CHO cells creates a gain-of-function system to study receptor signaling, desensitization, and drug efficacy. This is useful for high-throughput screening of antagonists.
How EDITGENE Supports thromboxane A2 receptor activity Research
Researchers studying thromboxane A2 receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor expression, signaling, or downstream physiology. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for thromboxane A2 receptor activity research.
Frequently Asked Questions About thromboxane A2 receptor activity
What is thromboxane A2 receptor activity?
Thromboxane A2 receptor activity (GO:0004961) is the molecular function of binding thromboxane A2 and transmitting a signal across the membrane to activate an associated G-protein [QuickGO].
What genes are involved in thromboxane A2 receptor activity?
Key genes include TBXA2R (the receptor), TBXAS1 (synthase), PTGS1/PTGS2 (cyclooxygenases), and G-protein subunits such as GNAQ, GNA12, GNA13, and GNAI1 [2,3,7].
How does the thromboxane A2 receptor signal?
It couples to Gq, G12/13, and Gi, activating phospholipase C, Rho kinase, and inhibiting adenylyl cyclase, respectively.
What diseases are associated with thromboxane A2 receptor activity?
It is linked to thrombosis, atherosclerosis, hypertension, non-alcoholic fatty liver disease, and neurovascular disorders [3,5,6,7].
Can flavonoids inhibit thromboxane A2 receptor activity?
Yes, certain flavonoids act as antagonists of the TXA2 receptor, as shown by structure-activity relationship studies.
What regulates the surface expression of the thromboxane A2 receptor?
Pim kinases regulate constitutive surface expression of the TXA2 receptor.
How can I study thromboxane A2 receptor activity in the lab?
Common methods include radioligand binding, GTPgammaS binding, calcium imaging, and CRISPR knockout screens [4,7,8].
What is the role of TXA2 receptor in the liver?
The TXA2/TXA2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress.
Does thromboxane A2 receptor activity affect angiogenesis?
Yes, it drives a COX-2-dependent feedback loop that affects endothelial homeostasis and angiogenesis.
What CRISPR models are available for TXA2 receptor research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for TBXA2R and related genes, as well as CRISPR library screening.
Conclusion
Thromboxane A2 receptor activity (GO:0004961) is a fundamental molecular function with broad implications for cardiovascular, metabolic, and inflammatory biology. Its receptor, TBXA2R, couples to multiple G-proteins to regulate platelet aggregation, vascular tone, and gene expression. Dysregulation contributes to thrombosis, insulin resistance, and neurovascular disorders. Understanding this activity through CRISPR-based models and pharmacological tools will continue to yield therapeutic insights. EDITGENE provides comprehensive services to support such research.
References
- 1. Lantz C et al.. 2025. Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration.. Immunity 58(2):344-361.e7 PMID: 39938482
- 2. Kontogiorgis C et al.. 2010. Thromboxane synthase inhibitors and thromboxane A2 receptor antagonists: a quantitative structure activity relationships (QSARs) analysis.. Curr Med Chem 17(28):3162-214 PMID: 20666724
- 3. Eckenstaler R et al.. 2022. A Thromboxane A(2) Receptor-Driven COX-2-Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis.. Arterioscler Thromb Vasc Biol 42(4):444-461 PMID: 35236104
- 4. Nock SH et al.. 2025. Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent.. J Thromb Haemost 23(1):293-305 PMID: 39798965
- 5. Dai Y et al.. 2024. Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non-alcoholic fatty liver disease.. Br J Pharmacol 181(7):967-986 PMID: 37940413
- 6. Woodruff S et al.. 2025. Kinetics of thromboxane A2 receptor-driven vascular tone in the cerebral cortex ex vivo.. Microvasc Res 161:104835 PMID: 40614800
- 7. Honma S et al.. 2006. Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change.. Eur J Pharmacol 545(2-3):100-8 PMID: 16876780
- 8. Navarro-Núñez L et al.. 2009. Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships.. J Agric Food Chem 57(4):1589-94 PMID: 19182941
